Pneumococci causing invasive disease in New Zealand, 1987-94: Serogroup and serotype coverage and antibiotic resistances

New Zealand Medical Journal

Volumn 109, Issue 1027, 1996, Pages 288-290

  Martin, Diana R ^a   Brett, Maggie S ^a  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD GROUP TYPING; CHILD; CONTROLLED STUDY; HUMAN; MULTIDRUG RESISTANCE; NEW ZEALAND; NONHUMAN; PENICILLIN RESISTANCE; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT; MIDDLE AGED; NEW ZEALAND; PNEUMOCOCCAL INFECTIONS; RETROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0029815060     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992; 11 (Suppl 8): S7-11.
2. Baltimore RS. New challenges in the development of a conjugate pneumococcal vaccine. JAMA 1992; 268: 3366-7.
3. Eskola J, Käyhty H, Takala AK, et al. A randomised, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engi J Med 1990; 323: 1381-7.
4. Baltimore RS. New challenges in the development of a conjugate pneumococcal vaccine. JAMA 1992; 268: 3366-7.
5. Sniadack DH, Schwartz B, Lipman H, et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children - implications for vaccine strategies. Pediatr Infect Dis J 1995; 14: 503-10.
6. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae. An overview. Clin Infect Dis 1992; 15: 77-83.
7. Heffernan H. Antimicrobial susceptibility of clinically significant Streptococcus pneumoniae isolates. NZ Med J 1987; 100: 327.
8. Lund E, Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. In: Bergan T, Norris R, eds. Methods in microbiology v.12. London: Academic Press, 1978; 241-62.
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - 3rd ed. Approved standard. Villanova, (PA): The Committee, 1993. NCCLS document M7-A3.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; fifth informational supplement. Vilianova, (PA); The Committee, 1994. NCCLS document M100-S5.
11. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-96.
12. Voss L, Lennon D, Kara O, Ameratunga S, Martin D. Invasive pneumococcal disease in a paediatric population, Auckland, New Zealand. Pediatr Infect Dis J 1994; 13: 87M.
13. McFarlane JT, Finch RG, Ward MJ, Macrae AD. Hospital study of adult community-acquired pneumonia. Lancet 1982; 2: 255-8.
14. Trotman J, Hughes B, Mollison L. Invasive pneumococcal disease in central Australia. Clin Infect Dis 1995; 20: 1553-6.
15. Magnus T, Andersen BM. Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in Northern Norway. Eur J Clin Microbiol Infect Dis 1995; 14: 229-34.
16. Lund E. Distribution of age and sex in cases of pneumococcal meningitis. Acta Path Microbiol Scand 1964; 61: 487-90.
17. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis 1995; 171: 885-9.
18. Verhaegen J, Glupczynski Y, Verbist L, et al. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clin Infect Dis 1995; 20: 1339-45.
19. Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271: 1831-5.
20. Brett M. Antimicrobial resistance: a potential threat for New Zealand. NZ Public Health Rep 1995; 2: 59-60.
21. Friedland IR, Shelton S, Paris M, et al. Dilemmas in diagnosis and management of cephalosporin-resistent Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1993; 12: 196-200.
22. Klugman KP, Saunders J. Pneumococci resistant to extended-spectrum cephalosporins in South Africa. Lancet 1993; 341: 1164.
23. Linares J, Alonso T, Perez JL, et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics. J Antimicrob Chemother 1992; 30: 279-88.